EXCLUSIVE: Rina Sawayama (John Wick: Chapter 4, Turn Up Charlie) joins the Apple TV+ romcom Prodigies cast alongside creator Will Sharpe and Ayo Edebiri, who also executive produce. The series ...

What you’re looking at is the Automobili Mignatta (or AM for short) Rina. And no, the name isn’t supposed to be a nautical nod to Riva – we’re told it was inspired by the founder of AM’s ...

Automobili Mignatta, a new Italian automaker, has debuted the Rina—a sports car with no windshield and a sleek carbon-fiber body. Under the hood lies a naturally aspirated V-8 that feeds the ...

Rina is set to star alongside Donnie Yen in the new spin-off film, and the 61-year-old actor — who is also directing Caine — is thrilled be reuniting with the singer-turned-actress.

Akira is coming back for more John Wick ass-kicking. Rina Sawayama, who became a fan-favourite as the fearless daughter of Hiroyuki Sanada’s Shimazu Koji in “John Wick: Chapter 4,” will ...

Here’s some good news for fans of Rina Sawayama’s John Wick 4 assassin scion: Sawayama is confirmed to return as Shimazu Akira in the upcoming spinoff, Caine. According to Billboard ...

This time she will play opposite star and director Donnie Yen. By Gil Kaufman Rina Sawayama is headed back to the Wick-everse. The singer/actress who made her big screen debut in 2023 in John Wick ...

But what a group of artists launching a brand? That seems to be the case for a mysterious new beauty initiative called Godmode, which counts Rina Sawayama and actress Chloe Grace Moretz as its co ...

Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer. Rinatabart sesutecan (Rina-S) is an antibody-drug conjugate that targets ...

Treatment with Rina-S showed antitumor activity in heavily pretreated patients with advanced ovarian cancer, according to the phase 2 RAINFOL-01 study. Treatment with rinatabart sesutecan (Rina-S), a ...

COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) announced today new data from the Phase 1/2 study of rinatabart sesutecan (Rina-S), an investigational folate receptor-alpha (FRα ...